Frontiers in Psychiatry (Apr 2024)

Assessment of anxiety in children with neurodevelopment disorders: Rasch analysis of the Spence Children’s Anxiety Scale

  • Alana Sparks,
  • Susan Gilbert Evans,
  • Mojib Javadi,
  • Bianca Lasalandra,
  • Emily Martens,
  • Raadhika Venkatesh,
  • Izzy T. Vaccarino,
  • Anthony L. Vaccarino

DOI
https://doi.org/10.3389/fpsyt.2024.1240357
Journal volume & issue
Vol. 15

Abstract

Read online

Anxiety is common in neurodevelopmental disorders (NDD). The parent version of the Spence Children’s Anxiety Scale (SCAS-P) is a widely used measure to assess anxiety across a broad range of childhood populations. However, assessment of the measurement properties of the SCAS-P in NDDs have been limited. The present study aimed to assess the psychometric properties of the SCAS-P in children with attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) using Rasch Measurement Theory. Data from the Province of Ontario Neurodevelopmental Disorders Network Registry were used in the analysis. Children (ages 6-13 years old) with a primary diagnosis of ADHD (n=146) or ASD (n=104) were administered the SCAS-P. Rasch Measurement Theory was used to assess measurement properties of the SCAS-P, including unidimensionality and item-level fit, category ordering, item targeting, person separation index and reliability and differential item functioning. The SCAS-P fit well to the Rasch model in both ADHD and ASD, including unidimensionality, satisfactory category ordering and goodness-of-fit. However, item-person measures showed poor precision at lower levels of anxiety. Some items showed differential item functioning, including items within the obsessive-compulsive, panic/agoraphobia and physical injury fears domains, suggesting that the presentation of anxiety may differ between ADHD and ASD. Overall, the results generally support the use of the SCAS-P to screen and monitor anxiety symptoms in children with ADHD and ASD. Future studies would benefit from examination of more severely anxious NDD cohort, including those with clinically diagnosed anxiety.

Keywords